Generation of two human induced pluripotent stem cell lines from peripheral blood mononuclear cells featuring normal or mutated STAB1 gene




Sandelin, Sanne; Giannareas, Nikolaos; Kere, Juha; Seppänen, Mikko R. J.; Hollmen, Maija; Närvä, Elisa

PublisherElsevier

AMSTERDAM

2025

Stem Cell Research

STEM CELL RESEARCH

STEM CELL RES

103750

87

5

1873-5061

1876-7753

DOIhttps://doi.org/10.1016/j.scr.2025.103750

https://doi.org/10.1016/j.scr.2025.103750

https://research.utu.fi/converis/portal/detail/Publication/498990284



Here, we report the establishment of a human induced pluripotent stem cell (hiPSC) line TUR-STAB1-B1 derived from peripheral blood mononuclear cells of a patient carrying heterozygous mutations 52,509,890 C>A 790L>I and 52,520,515 G>A 1872R>H on STAB1 gene in addition to a normal control cell line TUR-B1. The pluripotency, identity, quality, safety, and sequence of the mutation sites of the cell lines were confirmed. The generated patient-specific cell line will facilitate detailed studies of the STAB1 in various differentiated cell types.


This work was supported by funding from ImmuDocs (Finnish National Doctoral Education Pilot), BioCity Turku Funding, Finland; Finnish Red Cross Blood Service, Finland; Sigrid Jusélius Foundation, Finland; Drug Research Doctoral Programme (DRDP), InFlames, The Foundation for Pediatric Research, Pediatric Research Center HUS Helsinki University Hospital Research Funds, Finland; and Emil Aaltonen Foundation, Finland.


Last updated on 2025-12-08 at 14:46